Cargando…
Timing of Graves’ Hyperthyroidism Management in Pregnant Women: Impact on the Infant Thyroid Volume
The thyroid of the fetus of a mother with Graves’ disease (GD) is affected by the transplacental passage of both antithyroid drugs (ATDs) and thyroid-stimulating hormone receptor antibodies (TRAb). Thyroid hormone imbalances are harmful for the developing brain. This study aimed to evaluate the impa...
Autores principales: | Mikołajczak, Aleksandra, Bokiniec, Renata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102435/ https://www.ncbi.nlm.nih.gov/pubmed/35565939 http://dx.doi.org/10.3390/nu14091972 |
Ejemplares similares
-
Correlation Between Thyroid Hormone Concentrations and Ultrasound Thyroid Volume in Preterm Infants Born Before 33 Weeks of Gestation
por: Mikołajczak, Aleksandra, et al.
Publicado: (2022) -
Age-specific correlation between thyroid hormone concentrations and ultrasound thyroid volume for diagnosing thyroid dysfunction in preterm infants: a single-centre, prospective, observational study protocol
por: Mikołajczak, Aleksandra, et al.
Publicado: (2021) -
Radioiodine Thyroid Ablation in Graves’ Hyperthyroidism: Merits and Pitfalls
por: Nwatsock, J. F., et al.
Publicado: (2012) -
Pharmacodynamic Response to Anti-thyroid Drugs in Graves' Hyperthyroidism
por: Abbara, Ali, et al.
Publicado: (2020) -
Management of Graves’ hyperthyroidism and orbitopathy in time of COVID-19 pandemic
por: Bartalena, L., et al.
Publicado: (2020)